These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15488796)

  • 21. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
    Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
    Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
    Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pars plana vitrectomy in cystoid macular edema of different forms of chronic uveitis].
    Wiechens B; Reichelt JA; Urbat C; Nölle B
    Ophthalmologe; 2003 Jan; 100(1):33-43. PubMed ID: 12557024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N; Delicha E; Masselos S; Sfikakis PP
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography.
    Tran TH; de Smet MD; Bodaghi B; Fardeau C; Cassoux N; Lehoang P
    Br J Ophthalmol; 2008 Jul; 92(7):922-7. PubMed ID: 18577643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.
    Nguyen QD; Tatlipinar S; Shah SM; Haller JA; Quinlan E; Sung J; Zimmer-Galler I; Do DV; Campochiaro PA
    Am J Ophthalmol; 2006 Dec; 142(6):961-9. PubMed ID: 17046701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
    Lopez-Gonzalez R; Loza E; Jover JA; Benitez Del Castillo JM; Mendez R; Hernandez-Garcia C; Pato E
    Scand J Rheumatol; 2009; 38(1):58-62. PubMed ID: 18991187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
    Theodossiadis PG; Markomichelakis NN; Sfikakis PP
    Retina; 2007; 27(4):399-413. PubMed ID: 17420690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Course of macular edema in uveitis under medical treatment.
    Markomichelakis NN; Halkiadakis I; Pantelia E; Georgalas I; Chrysanthi K; Theodossiadis P; Moschos M; Theodossiadis G; Kouvatseas G
    Ocul Immunol Inflamm; 2007; 15(2):71-9. PubMed ID: 17558831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective case review of pediatric patients with uveitis treated with infliximab.
    Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
    Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM; Martinez-de-la-Casa JM; Pato-Cour E; Méndez-Fernández R; López-Abad C; Matilla M; Garcia-Sanchez J
    Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
    Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
    Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion.
    Park CH; Scott AW; Fekrat S
    Retina; 2007 Oct; 27(8):1020-5. PubMed ID: 18040238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
    Ozdemir H; Karacorlu M; Karacorlu S
    Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab as a treatment option for refractory endogenous anterior uveitis.
    Tappeiner C; Heinz C; Specker C; Heiligenhaus A
    Ophthalmic Res; 2007; 39(3):184-6. PubMed ID: 17534119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.